Among these PANoptosis driver proteins, AIM2 has been reported to play an inhibitory role in regulating the growth and metastasis of HCC by regulating immune cell infiltration, indicating that AIM2 can be used as a potential therapeutic target for HCC [21, 22]. The gene discussed is AIM2; the disease is hepatocellular carcinoma.